M Stares, E Doyle, S Chapple, G Raynes, J MacDonald… - Lung Cancer, 2024 - Elsevier
Background Most patients with advanced non-small cell lung cancer (NSCLC) treated with
first-line pembrolizumab monotherapy will experience progressive disease (PD). Only a …